Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model
Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
